ARCHIVES

Gleevec Produces 59% Response Rate In Gastrointestinal Stromal Tumors

This article is from The Cancer Letter archive.

Vol. 24 No. 5 | May 25, 2001

Download PDF Visit The Full Archive

Related Articles

Mozobil Plus G-CSF Increases Rate Of Cell Mobilization

September 30, 2005

In Brief: Monaco, Yarbro Named To Pharmacopeial Board; Gene Therapy Trial For ADA Clears First Hurdle

March 23, 1990

NIH scientists defend industry ties while officials vow conflicts review; three investigations planned.

January 23, 2004

ECOG, ACRIN Form Single Cooperative Group

May 18, 2012

Moses To Lead AACI.

October 19, 2001

Clearinghouse Completes Review of Backlog, Funds What Caused It, Reports On Program Value

May 19, 1978